Skip to main content
Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
114.23
+1.81 (1.61%)
Dec 20, 2024, 4:00 PM EST - Market closed

Abbott Laboratories Revenue by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Medical Devices
18.38B 17.88B 17.44B 16.89B 16.19B 15.56B 15.02B 14.69B
Medical Devices Growth
13.48% 14.90% 16.10% 14.98% 10.27% 5.83% 2.81% 2.23%
Diagnostics
9.36B 9.39B 9.51B 9.99B 10.76B 11.98B 13.99B 16.58B
Diagnostics Growth
-13.05% -21.61% -31.97% -39.77% -39.39% -33.41% -17.32% 6.01%
Nutrition
8.32B 8.33B 8.26B 8.15B 7.93B 7.66B 7.53B 7.46B
Nutrition Growth
4.90% 8.80% 9.60% 9.32% 3.24% -4.28% -7.61% -10.07%
Established Pharmaceuticals
5.15B 5.11B 5.10B 5.07B 5.06B 5.02B 4.95B 4.91B
Established Pharmaceuticals Growth
1.74% 1.83% 3.01% 3.14% 3.29% 3.72% 3.32% 4.11%
Other
15.00M 15.00M 14.00M 14.00M 13.00M 12.00M 11.00M 11.00M
Other Growth
15.38% 25.00% 27.27% 27.27% 18.18% -36.84% -71.79% -78.85%

Revenue by Geography
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
International
25.29B 25.18B 24.96B 24.66B 24.24B 24.23B 24.37B 25.51B
International Growth
4.33% 3.93% 2.40% -3.35% -7.68% -8.56% -8.97% -3.49%
United States
15.93B 15.55B 15.37B 15.45B 15.72B 16.00B 17.13B 18.14B
United States Growth
1.33% -2.83% -10.29% -14.83% -16.27% -16.02% -3.43% 9.01%

Operating Expense Breakdown
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Selling, General, and Administrative
11.51B 11.34B 11.15B 10.95B 11.20B 11.21B 11.22B 11.25B
Selling, General, and Administrative Growth
2.82% 1.21% -0.69% -2.66% -1.10% -1.35% -0.93% -0.67%
Research and Development
2.80B 2.75B 2.77B 2.74B 2.77B 2.88B 2.85B 2.89B
Research and Development Growth
1.05% -4.24% -2.60% -5.09% -5.44% 2.17% 2.15% 5.32%
Amortization
1.89B 1.92B 1.95B 1.97B 1.98B 1.98B 1.99B 2.01B
Amortization Growth
-4.39% -3.18% -2.26% -2.33% -2.46% -3.41% -2.83% -1.66%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.